SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-14-003966
Filing Date
2014-08-14
Accepted
2014-08-14 09:01:15
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_081414.htm 10-Q 398103
2 EXHIBIT 3.1 exh_31.htm EX-3.1 106413
3 EXHIBIT 31.1 exh_311.htm EX-31.1 13765
4 EXHIBIT 31.2 exh_312.htm EX-31.2 14079
5 EXHIBIT 32 exh_321.htm EX-32 6860
  Complete submission text file 0001171843-14-003966.txt   2097742

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT caps-20140630.xml EX-101.INS 165097
7 XBRL TAXONOMY EXTENSION SCHEMA caps-20140630.xsd EX-101.SCH 22692
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE caps-20140630_cal.xml EX-101.CAL 28541
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE caps-20140630_def.xml EX-101.DEF 104941
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE caps-20140630_lab.xml EX-101.LAB 150614
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE caps-20140630_pre.xml EX-101.PRE 124899
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21214 | Film No.: 141039685
SIC: 2834 Pharmaceutical Preparations